Pierre-luc Mouchel
Toulouse, 31059, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 26, 2025
The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: January 02, 2025
CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia.
Journal: Cancer research
Published: November 22, 2022
Chronic myeloid leukemia revealed through focal bone lesions responding to imatinib: The bee's knees.
Journal: Joint bone spine
Published: November 16, 2020
Massive pneumomediastinum due to perforated pneumatosis cystoides in graft-versus-host disease.
Journal: British journal of haematology
Published: October 20, 2020
First case of classical Hodgkin-like EBV-positive lymphoproliferative disorder under ruxolitinib therapy.
Journal: American journal of hematology
Published: October 07, 2020
Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia.
Journal: Cancers
Published: September 07, 2020
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.
Journal: Nature communications
Published: August 11, 2020
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia.
Journal: Nature cancer
Published: June 09, 2020
Dendrogenin A synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo.
Journal: Cancers
Published: May 21, 2020
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia.
Journal: The Journal of experimental medicine
Published: May 07, 2020
Last Updated: 09/26/2026